Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol Infusion [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating whether naltrexone reduces alcohol craving and alters brain activity during alcohol infusion in individuals with alcohol use disord…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcohol Dependence, Alcoholism | EARLY_Phase 1 | Status: COMPLETED